<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36836071</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Cardiopulmonary Long-Term Sequelae in Patients after Severe COVID-19 Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1536</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12041536</ELocationID><Abstract><AbstractText>We aimed to identify cardiopulmonary long-term effects after severe COVID-19 disease as well as predictors of Long-COVID in a prospective registry. A total of 150 consecutive, hospitalized patients (February 2020 and April 2021) were included six months post hospital discharge for a clinical follow-up. Among them, 49% experienced fatigue, 38% exertional dyspnea and 75% fulfilled criteria for Long-COVID. Echocardiography detected reduced global longitudinal strain (GLS) in 11% and diastolic dysfunction in 4%. Magnetic resonance imaging revealed traces of pericardial effusion in 18% and signs of former pericarditis or myocarditis in 4%. Pulmonary function was impaired in 11%. Chest computed tomography identified post-infectious residues in 22%. Whereas fatigue did not correlate with cardiopulmonary abnormalities, exertional dyspnea was associated with impaired pulmonary function (OR 3.6 [95% CI: 1.2-11], <i>p</i> = 0.026), reduced GLS (OR 5.2 [95% CI: 1.6-16.7], <i>p</i> = 0.003) and/or left ventricular diastolic dysfunction (OR 4.2 [95% CI: 1.03-17], <i>p</i> = 0.04). Predictors of Long-COVID included length of in-hospital stay (OR: 1.15 [95% CI: 1.05-1.26], <i>p</i> = 0.004), admission to intensive care unit (OR cannot be computed, <i>p</i> = 0.001) and higher NT-proBNP (OR: 1.5 [95% CI: 1.05-2.14], <i>p</i> = 0.026). Even 6 months after discharge, a majority fulfilled criteria for Long-COVID. While no associations between fatigue and cardiopulmonary abnormalities were found, exertional dyspnea correlated with impaired pulmonary function, reduced GLS and/or diastolic dysfunction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niebauer</LastName><ForeName>Julia Hanne</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binder-Rodriguez</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6060-7910</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iscel</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schedl</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capelle</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahr</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadjo</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schamilow</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badr-Eslam</LastName><ForeName>Roza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtenauer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, University Hospital Salzburg, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toma</LastName><ForeName>Aurel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoufaly</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Sigmund Freud University, 1020 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valenta</LastName><ForeName>Rosmarie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charwat-Resl</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krestan</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hitzl</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-7696-1479</Identifier><AffiliationInfo><Affiliation>Team Biostatistics and Publication of Clinical Trial Studies, Research and Innovation Management (RIM), Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology and Optometry, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Program Experimental Ophthalmology and Glaucoma Research, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenisch</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonderman</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">heart</Keyword><Keyword MajorTopicYN="N">long-term impairment</Keyword><Keyword MajorTopicYN="N">lung</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>3</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36836071</ArticleId><ArticleId IdType="pmc">PMC9959779</ArticleId><ArticleId IdType="doi">10.3390/jcm12041536</ArticleId><ArticleId IdType="pii">jcm12041536</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Di Fazio N., Delogu G., Bertozzi G., Fineschiw V., Frati P. SARS-CoV-2 Vaccination Adverse Events Trend in Italy: A Retrospective Interpretation of the Last Year (December 2020&#x2013;September 2021) Vaccines. 2022;10:216. doi: 10.3390/vaccines10020216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020216</ArticleId><ArticleId IdType="pmc">PMC8880467</ArticleId><ArticleId IdType="pubmed">35214674</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit N.M., Churchill A., Nsair A., Hsu J.J. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am. Heart J. Plus Cardiol. Res. Pract. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sire A., Moggio L., Marotta N., Agostini F., Tasselli A., Ferrante V.D., Curci C., Calafiore D., Ferraro F., Bernetti A., et al. Impact of Rehabilitation on Fatigue in Post-COVID-19 Patients: A Systematic Review and Meta-Analysis. Appl. Sci. 2022;12:8593. doi: 10.3390/app12178593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app12178593</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S., Erdos E.J. Epidemiologie von Long-COVID: Ein Vorl&#xe4;ufiger Bericht. Deutsche Kurzfassung zum Gleichnamigen KCE-Bericht. AIHTA; Vienna, Austria: 2021. AIHTA-Projektberic 135a.</Citation></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J., Wolf A., Hoyo L., H&#xfc;ll E., Tadic M., Andre&#xdf; S., D&#x2019;Almeida S., Scharnbeck D., Roder E., Beschoner P., et al. Symptom burden correlates to impairment of diffusion capacity and exercise intolerance in long COVID patients. Sci. Rep. 2022;12:8801. doi: 10.1038/s41598-022-12839-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-12839-5</ArticleId><ArticleId IdType="pmc">PMC9130688</ArticleId><ArticleId IdType="pubmed">35614108</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A., Frati P., Del Duca F., Santoro P., Manetti A.C., La Russa R., Di Paolo M., Turillazzi E., Fineschi V. Myocardial Pathology in COVID-19-Associated Cardiac Injury: A Systematic Review. Diagnostics. 2021;11:1647. doi: 10.3390/diagnostics11091647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11091647</ArticleId><ArticleId IdType="pmc">PMC8472043</ArticleId><ArticleId IdType="pubmed">34573988</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M., Tincani A., Andreoli L., Cattalini M., Greenbaum A., Kanduc D., Alijotas-Reig J., Zinserling V., Semenova N., Amital H., et al. COVID-19 and autoimmunity. Autoimmun. Rev. 2020;19:102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M., Cari&#xf1;ena A., Moreno E., Rodr&#xed;guez N., Dom&#xed;nguez M.J., Casal A., Riveiro V., Diaz-Vieito M., Vald&#xe9;s L., &#xc1;lvarez J., et al. Post-COVID-19 functional status six-months after hospitalization. J. Infect. 2021;82:e31&#x2013;e33. doi: 10.1016/j.jinf.2020.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., Okell T., Sheerin F., Xie C., Mahmod M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. eClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla A., Ankermann T., Behrends U. S1-Leitlinie Long/Post-COVID. Pneumologie. 2022;76:855&#x2013;907. doi: 10.1055/a-1946-3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1946-3230</ArticleId><ArticleId IdType="pubmed">36479679</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks D., Solway S., Gibbons W.J. ATS Statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002;166:111&#x2013;117. doi: 10.1164/ajrccm.167.9.950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.167.9.950</ArticleId><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt J.-U., Pedrizzetti G., Lysyansky P., Marwick T.H., Houle H., Baumann R., Pedri S., Ito Y., Abe Y., Metz S., et al. Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging. J. Am. Soc. Echocardiogr. 2015;28:183&#x2013;193. doi: 10.1016/j.echo.2014.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.11.003</ArticleId><ArticleId IdType="pubmed">25623220</ArticleId></ArticleIdList></Reference><Reference><Citation>Galderisi M., Cosyns B., Edvardsen T., Cardim N., Delgado V., Di Salvo G., Donal E., Sade L.E., Ernande L., Garbi M., et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: An expert consensus document of the European association of cardiovascular imaging. Eur. Heart J. Cardiovasc. Imaging. 2017;18:1301&#x2013;1310. doi: 10.1093/ehjci/jex244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jex244</ArticleId><ArticleId IdType="pubmed">29045589</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., Flachskampf F.A., Foster E., Goldstein S.A., Kuznetsova T., et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2015;28:1&#x2013;39.e14. doi: 10.1016/j.echo.2014.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Zampino R., Durante-Mangoni E., Iossa D., Ursi M.P., D&#x2018;Amico F., Karruli A., Andini R., Bernardo M., et al. Cardiac sequelae after coronavirus disease 2019 recovery: A systematic review. Clin. Microbiol. Infect. 2021;27:1250&#x2013;1261. doi: 10.1016/j.cmi.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Fern&#xe1;ndez A., Wamil M., Telford A., Carapella V., Borlotti A., Monteiro D., Thomaides-Brears H., Dennis A., Banerjee R., Robson M.D., et al. Cardiac impairment in Long COVID 1-year post-SARS-CoV-2 infection. Eur. Heart J. 2022;43((Suppl. S2)):ehac544-219. doi: 10.1093/eurheartj/ehac544.219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac544.219</ArticleId><ArticleId IdType="pmc">PMC9950586</ArticleId><ArticleId IdType="pubmed">36822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., Kumar K., Vimalesvaran K., Thornton G., Patel R., Chacko L., Brown J.T., Coyle C., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 2021;42:1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran D.H., Gupta A., Verceles A.C., Chow R.D. COVID-19 Presenting as Recurrent Pericardial Effusion. Cureus. 2021;13:e18652. doi: 10.7759/cureus.18652.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18652</ArticleId><ArticleId IdType="pmc">PMC8509094</ArticleId><ArticleId IdType="pubmed">34659927</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., Li Y., Cao Y., Gu J., Wu H., et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299:E177&#x2013;E186. doi: 10.1148/radiol.2021203153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>You J., Zhang L., Ni-Jia-Ti M.-Y., Zhang J., Hu F., Chen L., Dong Y., Yang K., Zhang B., Zhang S. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J. Infect. 2020;81:e150&#x2013;e152. doi: 10.1016/j.jinf.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7273134</ArticleId><ArticleId IdType="pubmed">32512021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X., Jian W., Su Z., Chen M., Peng H., Peng P., Lei C., Chen R., Zhong N., Li S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 2020;55:2001217. doi: 10.1183/13993003.01217-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., Bontempo G., Marrella F., Tommasini A., Fabris M., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D., Crawley E., Hautvast J., Katz B.Z., Knoop H., Little P., Taylor R., et al. Long COVID and Post-infective Fatigue Syndrome: A Review. Open Forum Infect. Dis. 2021;8:ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostojic S. Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome. Nutrients. 2021;13:503. doi: 10.3390/nu13020503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020503</ArticleId><ArticleId IdType="pmc">PMC7913646</ArticleId><ArticleId IdType="pubmed">33557013</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>